NSB 4.88% 3.9¢ neuroscientific biopharmaceuticals ltd

I think we need to progress in clinical trials.Phase 1 results...

  1. 171 Posts.
    lightbulb Created with Sketch. 38
    I think we need to progress in clinical trials.

    Phase 1 results could be vastly different to initial in vitro studies.

    if phase 1 is successful, i can see this easily reach 200-300m plus mc.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.